Table 3.
Overview of YBOCS outcomes for the different targets after DBS surgery at maximum follow-up.
| Target | N | Pre-DBS median | Post-DBS median | Median reduction | Median % change | p-value |
|---|---|---|---|---|---|---|
| CM-Pf | 11 | 17.60 (5.00) | 7.00 (11.60) | 5.60 (6.60) | 44.44 (50.13) | 0.102 |
| CM-Voi | 73 | 20.17 (3.17) | 11.45 (0.45) | 8.72 (2.92) | 43.23 (0.00) | <0.001 |
| amGPI | 36 | 19.50 (11.43) | 10.69 (4.12) | 11.50 (15.55) | 55.17 (46.42) | <0.001 |
| pvlGPi | 23 | 24.70 (7.00) | 3.20 (9.30) | 16.50 (10.50) | 87.04 (30.15) | <0.001 |
Measures of dispersion in brackets are interquartile ranges. P-values represents the results of Wilcoxon signed-rank tests comparing pre- and post-surgery YBOCS scores at maximum follow-up for each target.